EuroGRAFT
Members Area COST Action number CA17138

Working
Groups

This Action brought together Chronic GvHD (cGvHD) researchers across Europe for the first time, creating a network of cross-disciplinary experts in the field.

Working Group 1

Epidemiology

Lead

Daniel Wolff

Country

Germany

Email

daniel.wolff@ukr.de

Vice Lead

Drazen Pulanic

Dr Pulanic is a specialist of Internal Medicine and Subspecialist in Hematology in the department of Internal Medicine, University Hospital Center Zagreb and Medical School University of Zagreb, Croatia.

Drazen Pulanic

Country

Croatia

Email

dpulanic@yahoo.com

Overview

The development of an epidemiological platform on cGvHD within EUROGRAFT was a novel approach to understanding the disease incidence and associated comorbidities.

Other working groups

Biomarkers

This Working Group will assess the type and amount of biomarker information which is currently available in the literature and assess those which are worthy of further validation and study.

Socioeconomics/Quality of life

CGvHD is a long term complex disease which has several co-morbidities and as such impacts on the quality of life of patients. By studying the societal impact of the disease via documented quality of life assessments, including reduced working days due to hospital stays, EUROGRAFT will allow an improved assessment of the burden on society of cGvHD at both the individual and European level.

NIH Consensus

The NIH consensus criteria needs to be implemented uniformly if diagnosis and treatment of
cGVHD is to be optimized. The aim of this Working Group will be to aid in both the understanding and
implementation of the NIH Consensus via Training Schools and workshops.

Are you interested
in taking part?

If you would like to join the network, have a general query or any suggestion, please connect with us.

Contact us

Get involved

Do you have a question?

If you have any questions or would like to know more about the project, simply connect with us and we’ll be happy to talk to you.